Details of the Drug

General Information of Drug (ID: DMSN21C)

Drug Name

TG4050

Indication

Disease Entry	ICD 11	Status	REF
Ovarian cancer	2C73	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03839524) A Trial Evaluating TG4050 in Ovarian Carcinoma.. U.S. National Institutes of Health.